PMID- 22613963 OWN - NLM STAT- MEDLINE DCOM- 20121016 LR - 20211203 IS - 1791-3004 (Electronic) IS - 1791-2997 (Linking) VI - 6 IP - 2 DP - 2012 Aug TI - Protective effect of transplanted bone marrow-derived mesenchymal stem cells on pancreatitis-associated lung injury in rats. PG - 287-92 LID - 10.3892/mmr.2012.922 [doi] AB - Severe acute pancreatitis (SAP) is initiated by the premature activation of digestive enzymes within the pancreatic acinar cells, leading to self-digestion and inflammatory responses in pancreatic ductal cells, thus giving rise to systemic inflammatory response syndrome (SIRS). The most common and serious SIRS is pancreatitis-associated lung injury, and inflammatory mediators play an important role in its pathogenesis. Bone marrow-derived mesenchymal stem cells (MSCs) are differentiated into alveolar endothelial cells to replace the damaged alveolar endothelial cells and inhibit inflammatory response in the injured lung tissues. In this study, we aimed to investigate the therapeutic effect of bone marrow-derived MSCs in rats with pancreatitis-associated lung injury. Experimental SAP was induced by a retrograde injection of 5% sodium taurocholate into the biliopancreatic duct of 75 male Sprague-Dawley rats, which were divided into the SAP group (n=25), the MSC group (n=25) and the sham-operated group (n=25) to explore the pathology and function of lung tissues and the regulation of inflammatory mediators. Pulmonary edema was estimated by measuring water content in the lung tissues. Pulmonary myeloperoxidase (MPO) activity was detected using spectrophotometry. Serum amylase was detected using the Automatic Biochemistry Analyzer. Tumor necrosis factor-alpha (TNF-alpha) and substance P (SP) mRNA levels were determined by quantitative reverse transcriptase-polymerase chain reaction. Our results showed that serum amylase activity was significantly decreased in the MSC group compared to the SAP group. Pulmonary edema was significantly diminished (p<0.05) in the MSC group compared to the SAP group. Typical acute lung injury was observed in the SAP group, and the pathological changes were mild in the MSC group. The expression of TNF-alpha and SP mRNA in lung tissue was diminished in the MSC group compared to the SAP group. In conclusion, MSC transplantation attenuates pulmonary edema and inflammation, and reduces the mRNA expression of TNF-alpha and SP in pancreatitis-associated lung injury. FAU - Wang, Lie AU - Wang L AD - Department of General Surgery, Fuzhou General Hospital of Nanjing Military Region, Fuzhou, Fujian 350025, PR China. FAU - Tu, Xiao-Huang AU - Tu XH FAU - Zhao, Peng AU - Zhao P FAU - Song, Jing-Xiang AU - Song JX FAU - Zou, Zhong-Dong AU - Zou ZD LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120521 PL - Greece TA - Mol Med Rep JT - Molecular medicine reports JID - 101475259 RN - 0 (Inflammation Mediators) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - 33507-63-0 (Substance P) RN - 5E090O0G3Z (Taurocholic Acid) RN - EC 1.11.1.7 (Peroxidase) RN - EC 3.2.1.- (Amylases) SB - IM MH - Acute Lung Injury/enzymology/metabolism/pathology/*therapy MH - Amylases/blood MH - Animals MH - Bone Marrow Cells/*cytology/metabolism MH - Disease Models, Animal MH - Enzyme Activation MH - Inflammation Mediators/blood MH - Lung/enzymology/metabolism/pathology MH - Male MH - Mesenchymal Stem Cell Transplantation/*methods MH - Mesenchymal Stem Cells/cytology/*metabolism MH - Pancreatitis/chemically induced/metabolism/*pathology MH - Peroxidase/metabolism MH - Pulmonary Edema/pathology/therapy MH - RNA, Messenger/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Reverse Transcriptase Polymerase Chain Reaction MH - Severity of Illness Index MH - Substance P/blood MH - Systemic Inflammatory Response Syndrome/chemically induced/therapy MH - Taurocholic Acid/administration & dosage/adverse effects MH - Tumor Necrosis Factor-alpha/blood OTO - NOTNLM OT - mesenchymal stem cells OT - severe acute pancreatitis OT - pancreatitis-associated lung injury OT - substance P OT - tumor necrosis factor-alpha EDAT- 2012/05/23 06:00 MHDA- 2012/10/17 06:00 CRDT- 2012/05/23 06:00 PHST- 2012/01/18 00:00 [received] PHST- 2012/04/10 00:00 [accepted] PHST- 2012/05/23 06:00 [entrez] PHST- 2012/05/23 06:00 [pubmed] PHST- 2012/10/17 06:00 [medline] AID - 10.3892/mmr.2012.922 [doi] PST - ppublish SO - Mol Med Rep. 2012 Aug;6(2):287-92. doi: 10.3892/mmr.2012.922. Epub 2012 May 21.